Who knows what these sp fluctuations mean? Just the short term...

Who knows what these sp fluctuations mean? Just the short term day traders taking their winnings or losses, or maybe some other investors losing their nerve just before the phase 2 trials begin. The important point is that phase 2 clinical trials are about to start. There is risk associated with this of course, but three years of laboratory work on PPL-1 and one year of phase 1 tests on humans give us confidence. At the present sp the company is basically being valued for little more than its Epichem unit, which is going well. Cheers